IFNA1 and Alzheimer disease: Our results suggested that 3TC treatment inhibited L1 induced by ageing in the brain and decreased the expression of genes related to IFN, SASP and AD, indicating that the signal pathways activated by ageing were suppressed by 3TC treatment.